Explore the latest in gastrointestinal cancer, including advances in management of esophageal, gastric, colorectal, and pancreatic malignancy.
This cohort study uses UK Biobank data to estimate the risk for primary hepatic carcinoma and cancer-related death by HFE variant status among community-dwelling individuals of European ancestry in England, Scotland, and Wales.
This nested case-control study evaluates the association between duration and recency of low-dose aspirin use and colorectal cancer risk in an East Asian population.
This decision analytical model study assesses the burden of hepatocellular carcinoma surveillance in the era of new hepatitis C antiviral treatments by projecting the number and the characteristics of new hepatocellular carcinoma incident cases and candidates for routine hepatocellular carcinoma surveillance.
This Medical News article examines how studying the characteristics of long-term pancreatic cancer survivors might improve treatment and boost survival for others who have the disease
This economic evaluation assesses the budget impact associated with adding avapritinib for metastatic or unresectable GIST in patients with a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 variant or after 3 or more previous treatments to a hypothetical US health plan formulary.
This randomized clinical trial assesses the efficacy of nivolumab plus ipilimumab in the treatment of patients with advanced hepatocellular carcinoma who have been previously treated with sorafenib.
A 73-year-old man with metastatic colorectal cancer presents with crusted lesions and purulent drainage on the scalp, with associated pruritus and pain. What is your diagnosis?
This cross-sectional study examines whether Medicaid expansion is associated with improved mortality among patients with breast, colorectal, and lung cancer.
This cohort study examined the association of adding ablative therapy to transarterial chemoembolization with overall survival and freedom from local progression among patients with hepatocellular carcinoma (HCC).
This Viewpoint discusses approvals by the US Food and Drug Administration for first- and second-line chemotherapy drugs—plus the combined use of some agents—used to treat hepatocellular carcinoma.
This randomized clinical trial compares the efficacy and safety of the anterior approach and conventional hepatectomy in patients undergoing resection for colorectal liver metastasis.
This case series examines data from 2003 to 2018 regarding patients who underwent aggressive resection operative treatment for locally advanced pancreatic neuroendocrine tumors and their outcomes in terms of disease recurrence, quality of life, and overall 5-year survival.
A 72-year-old man with metastatic appendiceal adenocarcinoma undergoing chemotherapy with capecitabine plus oxaliplatin presents with lower abdominal pain and watery, large-volume diarrhea up to 15 times per day for the previous 3 weeks. What is your diagnosis?
This case series examines HPV seropositivity and antibody levels in a cohort of older men who have sex with men.
This cohort study uses data from an existing cohort of patients undergoing resection of pancreatic cancer to assess the overall survival of patients treated with neoadjuvant FOLFIRINOX after surgery for pancreatic ductal adenocarcinoma.
This cohort study evaluates the association of coffee consumption with disease progression and death in patients with advanced or metastatic colorectal cancer.
This cohort study assesses the association between CDH1 variant pathogenicity or family history of cancer and signet ring cell cancer and describes outcomes of minimally invasive and open total gastrectomy.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: